0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn%E2%80%99s%20disease" gave back 49269 results.
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Highlights The global Incontinence & Ostomy Care market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Integrin Beta 7 - Pipeline Review, H2 2019 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Integrin beta-7 is an integrin...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
The wireless motility/pH capsule (WMC) is an orally ingested, nondigestible, data recording device that enables the simultaneous assessment of...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
Catalog:
La Merie Publishing
March 2014
Price: USD 551.00
The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- Global (48841) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Markets (1) Apply Emerging Markets filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
